$519 Million is the total value of Foyston, Gordon, & Payne Inc's 62 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was 11.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AON | Sell | AON PLC | $18,679,000 | -1.3% | 133,106 | -5.8% | 3.60% | -0.2% |
| AXP | Sell | American Express | $18,181,000 | -9.9% | 194,908 | -4.1% | 3.50% | -8.8% |
| MSI | Sell | Motorola Solutions Inc. | $17,231,000 | +12.7% | 163,639 | -3.3% | 3.32% | +14.1% |
| GNTX | Sell | Gentex Corp. | $16,493,000 | +3.0% | 716,445 | -6.3% | 3.18% | +4.2% |
| WFC | Sell | Wells Fargo Co. | $13,096,000 | -18.6% | 249,882 | -5.7% | 2.52% | -17.6% |
| BAX | Sell | Baxter International Inc. | $12,180,000 | -2.4% | 187,263 | -3.0% | 2.34% | -1.2% |
| PFE | Sell | Pfizer Inc. | $10,805,000 | -7.2% | 304,452 | -5.3% | 2.08% | -6.1% |
| JCI | Sell | Johnson Controls International PLC | $8,569,000 | -11.1% | 243,151 | -3.9% | 1.65% | -10.0% |
| CHRW | Sell | C.H. Robinson Worldwide Inc. | $7,625,000 | -2.8% | 81,363 | -7.6% | 1.47% | -1.6% |
| NVS | Sell | Novartis AG - ADR | $6,804,000 | -4.5% | 84,156 | -0.8% | 1.31% | -3.3% |
| SABR | Sell | Sabre Corp. | $6,792,000 | +2.1% | 316,666 | -2.4% | 1.31% | +3.3% |
| GWW | Sell | W.W. Grainger Inc. | $6,544,000 | -23.2% | 23,184 | -35.7% | 1.26% | -22.2% |
| CHKP | Sell | Check Point Software Technologies Ltd. | $6,160,000 | -7.6% | 62,010 | -3.6% | 1.19% | -6.5% |
| NVO | Sell | Novo Nordisk Spons ADR | $5,247,000 | -10.7% | 106,548 | -2.7% | 1.01% | -9.7% |
| FOXA | Sell | Twenty-First Century Fox Inc. | $5,060,000 | -18.6% | 137,908 | -23.4% | 0.97% | -17.6% |
| HSY | Sell | The Hershey Co. | $4,397,000 | -15.5% | 44,434 | -3.1% | 0.85% | -14.4% |
| SWK | Sell | Stanley Black & Decker Inc. | $4,318,000 | -13.6% | 28,188 | -4.2% | 0.83% | -12.5% |
| MRK | Sell | Merck & Co. Inc. | $3,922,000 | -7.0% | 72,004 | -3.9% | 0.76% | -5.9% |
| PX | Sell | Praxair Inc. | $3,759,000 | -12.6% | 26,050 | -6.3% | 0.72% | -11.5% |
| TTE | Sell | Total SA - ADR | $3,741,000 | +1.8% | 64,855 | -2.4% | 0.72% | +3.0% |
| DOX | Sell | Amdocs Ltd. | $3,672,000 | -5.5% | 55,036 | -7.2% | 0.71% | -4.3% |
| EMR | Sell | Emerson Electric Co. | $3,546,000 | -8.9% | 51,924 | -7.0% | 0.68% | -7.7% |
| TIF | Sell | Tiffany & Co. | $3,277,000 | -10.3% | 33,556 | -4.6% | 0.63% | -9.2% |
| CCU | Sell | Cia Cervecerias Unidas - ADR | $1,400,000 | -28.7% | 47,591 | -28.3% | 0.27% | -27.8% |
| SNY | Exit | Sanofi - ADR | $0 | – | -23,850 | -100.0% | -0.20% | – |
| RDSA | Exit | Royal Dutch Shell PLC ADR A | $0 | – | -59,069 | -100.0% | -0.75% | – |
| APA | Exit | Apache Corp. | $0 | – | -130,158 | -100.0% | -1.04% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-05-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Microsoft Corp. | 42 | Q3 2023 | 10.2% |
| Johnson & Johnson | 42 | Q3 2023 | 9.3% |
| Mondelez International Inc. | 42 | Q3 2023 | 4.0% |
| Coca Cola Co. | 42 | Q3 2023 | 1.7% |
| Berkshire Hathaway Inc. CL B | 42 | Q3 2023 | 1.6% |
| Becton Dickinson & Co. | 42 | Q3 2023 | 2.7% |
| Wal-Mart Stores Inc. | 42 | Q3 2023 | 0.9% |
| AbbVie Inc. | 42 | Q3 2023 | 0.5% |
| Abbott Laboratories | 42 | Q3 2023 | 0.4% |
| Procter & Gamble Co. | 42 | Q3 2023 | 0.2% |
View Foyston, Gordon, & Payne Inc's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Foyston, Gordon, & Payne Inc | September 20, 2012 | 4,798,387 | 4.8% |
| Foyston, Gordon, & Payne Inc | April 25, 2012 | 8,966,382 | 9.2% |
| TECUMSEH PRODUCTS CO | July 17, 2006 | 553,579 | 4.1% |
| CPI CORPSold out | April 27, 2006 | 0 | 0.0% |
View Foyston, Gordon, & Payne Inc's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-07 |
| 13F-HR | 2024-02-07 |
| 13F-HR | 2023-10-26 |
| 13F-HR | 2023-08-01 |
| 13F-HR | 2023-05-03 |
| 13F-HR | 2023-02-09 |
| 13F-HR | 2022-11-04 |
| 13F-HR | 2022-08-11 |
| 13F-HR | 2022-04-27 |
| 13F-HR | 2022-02-11 |
View Foyston, Gordon, & Payne Inc's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.